Bob Katter, MBA is president of First Databank.
Tell me about yourself and the company.
I’ve spent my entire career in healthcare, primarily health IT and a little bit of health services. Before…
Erin Crum, Sr. Director of Quality Strategy and Innovation, The US Oncology Network and McKesson
The Centers for Medicare and Medicaid Services (CMS) introduced the MIPS Value Pathways (MVPs) as part of its ongoing revisions…
Continue Reading
Top News
McKesson, Oracle, and NextGen Healthcare’s private equity owner Thoma Bravo are reportedly vying to acquire health IT, analytics, and data vendor Veradigm. A deal is expected to be reached by Thanksgiving.
Veradigm’s market…
What You Should Know:
– Ontada, a McKesson business specializing in oncology real-world data and evidence, has formed a strategic partnership with Microsoft to leverage the power of Azure AI in transforming cancer care.
– The…
Continue Reading
This week, HarmonyCares raked in $200 million dollars to scale its in-home primary care delivery model for high-risk senior patients. The funding round was led by General Catalyst, McKesson Ventures and an unnamed large…
Continue Reading
In-home, value-based longitudinal primary care provider HarmonyCares announced it secured $200 million in a funding round led by General Catalyst, a large national payor and McKesson Ventures. K2 HealthVentures and existing investors Valtruis, Rubicon Founders,…
Continue Reading
What You Should Know:
– HarmonyCares, a provider of value-based in-home longitudinal care, raises $200M to make its integrated, physician-led in-home care model available to more vulnerable patients nationwide.
– The funding round, led by General…
Continue Reading
California-based real-world data platform Atropos Health has secured $33 million in Series B funding.Valtruis led the investment round, which included new investors McKesson Ventures, Merck GHI Fund and Cencora Ventures.
Existing investors Emerson Collective, Breyer…
What You Should Know:
– Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $30 million Series B on the heels of the adoption of…
Continue Reading
What You Should Know:
– Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, today announced a $33 million Series B on the heels of the adoption of…
Continue Reading
